Yourgene Health Launches MagBench Automated DNA Extraction Instrument and Kit for NIPT Workflows
September 05 2023 - 3:17AM
Business Wire
Offers clinical labs in APAC and Middle East
cost-efficient, bench-top robotic cell-free DNA extraction
workstation and reagents for Yourgene’s Sage 32 NIPT Workflow
Yourgene Health plc (“Yourgene”, AIM: YGEN), a leading
international molecular diagnostics group, today launched the
Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit.
MagBench solution is available to Sage™ customers across
Asia-Pacific and the Middle East. MagBench offers a simple, fast,
and cost-efficient, bench-top robotic cell-free DNA (cfDNA)
extraction workstation optimised for Yourgene’s Sage 32 NIPT
Workflow. This provides clinical laboratories with a streamlined
end-to-end solution, from sample to report, enabling them to
provide a more accurate and competitive non-invasive prenatal
testing (NIPT) service.
The MagBench Automated DNA Extraction Instrument is easy to use,
quick to install and provides users with an intuitive touchscreen
user interface with built-in protocols, offering fast run times and
flexible sample throughput to meet the laboratory’s testing needs.
The MagBench Extraction Kit comprises sample and elution tubes,
pre-sealed cartridges with all the reagents needed for efficient
cfDNA purification, and individually packaged tip sets with a
unique cross-notch design for precise volume pipetting.
Increased automation during DNA extraction, limits hands-on
procedures, minimising the chance of human error and with
single-use tip disposal and a built-in UV lamp for decontamination
between runs, it minimises the risk of cross contamination. It also
helps improve the accuracy and consistency of pipetting, resulting
in a lower failure rate.
Sage Prenatal Screen offers a Safe,
Accurate, Genetic Evaluation of
placental DNA in maternal blood using next-generation sequencing in
three days. The NIPT workflow includes extracting DNA from the
maternal plasma using MagBench, followed by library preparation and
enrichment, sequencing, and Sage Link analysis to estimate the risk
of a fetus having trisomy 21, 18 or 13, rare autosomal
aneuploidies, sex chromosome aneuploidies and the most clinically
relevant microdeletions.
Dr Rob Henke, Vice President of Sales, Asia-Pacific at
Yourgene Health, said: “Yourgene is committed to delivering
best-in-class NIPT solutions, where precision and quality assurance
are key. MagBench enables an economical and automated NIPT
workflow. Reducing manual procedures improves user experience,
facilitating true walkaway time while minimising the risk of
contamination and improving testing accuracy. This decreases the
number of screening failures, greatly improves efficiency, and
helps lower expectant parents’ anxiety.”
Visit:
https://yourgenehealth.com/our-products/nipt-solutions/nipt/sage-prenatal-screen/magbench
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230905208175/en/
Codon Communications Michelle Ricketts +447789053885
michelle.ricketts@codoncommunications.com
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Dec 2024 to Jan 2025
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Jan 2024 to Jan 2025